Insulin glargine and lixisenatide Subcutaneous and Rescon JR
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Rescon JR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: dexchlorpheniramine / phenylephrine
Brand name:
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Rescon MX Tablets
- Insulin glargine and lixisenatide Subcutaneous-Rescon-DM
- Insulin glargine and lixisenatide Subcutaneous-Rescon-GG
- Insulin glargine and lixisenatide Subcutaneous-Rescriptor
- Insulin glargine and lixisenatide Subcutaneous-Rescula
- Insulin glargine and lixisenatide Subcutaneous-Rescula Ophthalmic Solution
- Rescon JR-Insulin glargine, recombinant Subcutaneous
- Rescon JR-Insulin glulisine
- Rescon JR-Insulin Glulisine (Cartridges and Pens)
- Rescon JR-Insulin Glulisine (Vials)
- Rescon JR-Insulin glulisine Subcutaneous
- Rescon JR-Insulin human inhaled Inhalation